Boehringer Ingelheim joins the Rare Disease Action Forum

    8 Mar, 2024

    We are delighted to announce Boehringer Ingelheim as new member of the Rare Disease Action Forum. Boehringer Ingelheim’s membership fortifies RDAF’s multi-stakeholder base, alongside other members from industry, patient organizations, healthcare professionals, and research institutions.

    We are looking forward to Boehringer Ingelheim’s valuable contributions to the collaborative initiatives within the RDAF platform. Together, we remain steadfast in our mission to enhance access to diagnosis, treatment, and care for individuals afflicted with rare diseases in Switzerland.

    Continue reading

    International Rare Disease Day in Switzerland

    The Rare Disease Action Forum (RDAF) supports the International Rare Disease Day, a worldwide campaign that promotes access to diagnosis and treatment for individuals living with a rare disease. Scheduled for 29 February 2024, this awareness day aims to address the...